Singh Bharati, Avula Kiran, Chatterjee Sanchari, Datey Ankita, Ghosh Arup, De Saikat, Keshry Supriya Suman, Ghosh Soumyajit, Suryawanshi Amol Ratnakar, Dash Rupesh, Senapati Shantibhusan, Beuria Tushar K, Prasad Punit, Raghav Sunil, Swain Rajeeb, Parida Ajay, Hussain Syed Gulam, Chattopadhyay Soma
Institute of Life Sciences, Bhubaneswar, India.
School of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar, India.
Front Microbiol. 2022 Jun 30;13:856913. doi: 10.3389/fmicb.2022.856913. eCollection 2022.
The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) as a serious pandemic has altered the global socioeconomic dynamics. The wide prevalence, high death counts, and rapid emergence of new variants urge for the establishment of research infrastructure to facilitate the rapid development of efficient therapeutic modalities and preventive measures. In agreement with this, SARS-CoV-2 strains were isolated from patient swab samples collected during the first COVID-19 wave in Odisha, India. The viral isolates were adapted to cultures and further characterized to identify strain-specific variations in viral growth characteristics. The neutralization susceptibility of viral isolates to vaccine-induced antibodies was determined using sera from individuals vaccinated in the Government-run vaccine drive in India. The major goal was to isolate and adapt SARS-CoV-2 viruses in cell culture with minimum modifications to facilitate research activities involved in the understanding of the molecular virology, host-virus interactions, drug discovery, and animal challenge models that eventually contribute toward the development of reliable therapeutics.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)作为一场严重的大流行病的出现,改变了全球社会经济动态。其广泛传播、高死亡人数以及新变种的迅速出现,促使建立研究基础设施,以促进高效治疗方法和预防措施的快速发展。与此一致的是,从印度奥里萨邦第一波新冠疫情期间收集的患者拭子样本中分离出了SARS-CoV-2毒株。将病毒分离株适应培养,并进一步进行特征分析,以确定病毒生长特性中的毒株特异性变异。使用在印度政府主导的疫苗接种活动中接种疫苗的个体的血清,测定病毒分离株对疫苗诱导抗体的中和敏感性。主要目标是在细胞培养中以最少的修饰分离和适应SARS-CoV-2病毒,以促进参与理解分子病毒学、宿主-病毒相互作用、药物发现和动物攻毒模型的研究活动,最终有助于开发可靠的治疗方法。